Search results for Lebrikizumab
Lebrikizumab, Abbexa, abx831187
Lebrikizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting IL13, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Lebrikizumab has been used in trials studying the treatment of Asthma, Allergic Asthma, Atopic Dermatitis, Idiopathic Pulmonary Fibrosis, and COPD, Chronic Obstructive Pulmonary Disease.
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Lebrikizumab Biosimilar - Research Grade, ichor.bio, ICH5058
Detects human IL-13. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Lebrikizumab.
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Research Grade Lebrikizumab (HW632026), abinScience, HW632026
Host
Humanized
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.